Advanced Glycation End Products and Cardiovascular Disease

被引:57
|
作者
Peppa, Melpomeni [1 ]
Raptis, Sotirios A. [1 ]
机构
[1] Attikon Univ Hosp, Res Inst & Diabet Ctr & Hel lenic Natl Diabet Ctr, Dept Internal Medicine Propaedeut 2, Endocrine Unit, Athens, Greece
关键词
Cardiovascular disease; Atherosclerosis; Oxidative stress; Inflammation; Arterial stiffening; Endothelium; Diet; Advanced glycation end products; AGEs; AGE-receptors; AGE-inhibitors; AGE-breakers;
D O I
10.2174/157339908784220732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Advanced glycation end products [AGEs] seem to play an important role for the development and/or progression of CVD mainly through induction of oxidative stress and inflammation. AGEs are a heterogenous group of molecules formed by the nonenzymatic reaction of reducing sugars with amino acids of proteins, lipids and nucleic acids. Recent studies suggest that in addition to those endogenously formed, diet constitutes an important exogenous source of AGEs. Diet-derived AGEs contribute to the whole body AGE pool and the AGE-related pathology. Recent in vitro and in vivo studies revealed significant correlations between diet-derived AGEs and several risk factors and/ or markers of CVD, suggesting the dietary AGEs restriction as a promising therapeutic intervention.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 50 条
  • [41] Effect of diet-derived advanced glycation end products on inflammation
    Kellow, Nicole J.
    Coughlan, Melinda T.
    NUTRITION REVIEWS, 2015, 73 (11) : 737 - 759
  • [42] Smooth Muscle Cell Pathophysiology and Advanced Glycation End Products (AGEs)
    Yamagishi, Sho-ichi
    Matsui, Takanori
    CURRENT DRUG TARGETS, 2010, 11 (07) : 875 - 881
  • [43] Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease
    Cooper, ME
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (12) : 31S - 38S
  • [44] Advanced glycation end products in the skin are enhanced in COPD
    Hoonhorst, Susan J. M.
    Loi, Adele T. Lo Tam
    Hartman, Jorine E.
    Telenga, Eef D.
    van den Berge, Maarten
    Koenderman, Leo
    Lammers, Jan Willem J.
    Boezen, H. Marike
    Postma, Dirkje S.
    ten Hacken, Nick H. T.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (09): : 1149 - 1156
  • [45] Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV
    El Kamari, Vanessa
    Thomas, Alicia
    Shan, Lingpeng
    Sattar, Abdus
    Monnier, Vincent
    Howell, Scott K.
    Beisswenger, Paul J.
    McComsey, Grace A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (02) : E55 - E62
  • [46] Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events
    Sprenger, Herman G.
    Bierman, Wouter F.
    Martes, Melanie I.
    Graaff, Reindert
    van der Werf, Tjip S.
    Smit, Andries J.
    AIDS, 2017, 31 (02) : 241 - 246
  • [47] Exercise, Advanced Glycation End Products, and Their Effects on Cardiovascular Disorders: A Narrative Review
    Hooshiar, Saeedeh Hosseini
    Esmaili, Helia
    Taherian, Amirmohammad
    Jafarnejad, Sadegh
    HEART AND MIND, 2022, 6 (03) : 139 - 150
  • [48] Role of advanced glycation end products in cellular signaling
    Ott, Christiane
    Jacobs, Kathleen
    Haucke, Elisa
    Santos, Anne Navarrete
    Grune, Tilman
    Simm, Andreas
    REDOX BIOLOGY, 2014, 2 : 411 - 429
  • [49] The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach
    Salahuddin, Parveen
    Rabbani, Gulam
    Khan, Rizwan Hasan
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2014, 19 (03) : 407 - 437
  • [50] Association of advanced glycation end products in Dupuytren disease
    Takase, Fumiaki
    Mifune, Yutaka
    Inui, Atsuyuki
    Ueda, Yasuhiro
    Kataoka, Takeshi
    Kokubu, Takeshi
    Kuroda, Ryosuke
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2018, 13